HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) CME: Take the course for this article: Volume 62, Number 9, May 11, 2004 Data Supplement Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Jeannet, P.-Y. Articles by Romero, N. B. Search for Related Content PubMed PubMed Citation Articles by Jeannet, P.-Y. Articles by Romero, N. B. Related Collections Muscle disease All Genetics

Clinical and histologic findings in autosomal centronuclear myopathy

From the Institut de Myologie and Unité Inserm 582, Groupe Hospitalier Pitié-Salpêtrière, Paris, France.

Address correspondence and reprint requests to Dr. Norma Beatriz Romero, Unité Iserm 582, Groupe Hospitalier Pitié-Salpêtrière, 47-83 Boulevard de l’Hôpital, 75651 Paris Cedex 13, France; e-mail: nb.romero{at}myologie.chups.jussieu.fr

Centronuclear myopathy (CNM) is a congenital myopathy characterized by chains of centrally located nuclei in a large number of muscle fibers. Clinically, an early-onset form was reported in several autosomal-recessive (AR) families and many sporadic patients, whereas a late-onset form was found in most autosomal-dominant (AD) families. The boundary between these two forms remains unclear, and the molecular basis of autosomal CNM is still unresolved. To better define the clinical and morphologic characteristics of autosomal CNM, the authors analyzed a series of 29 patients from 12 families. Two subgroups were identified in three AD families: two families had a relatively late onset of disease and a slow progression of diffuse weakness, whereas the third family, who had a similar clinical course, also presented a unique diffuse muscle hypertrophy. Two presumed AR families and seven sporadic patients were analyzed together, and three subgroups were identified: 1) an early-onset form with ophthalmoparesis; 2) an early-onset form without ophthalmoparesis; and 3) a late-onset form without ophthalmoparesis. Overall, 23 muscle biopsies were reviewed; a majority of patients had >20% central nuclei, fiber type 1 predominance, and a radial distribution of sarcoplasmic strands on oxidative stains. A marked endomysial fibrosis was observed in three sporadic patients with a relatively severe clinical course. The classification reported in this study will be useful for the diagnosis and the follow-up evaluation of patients with autosomal CNM and for the research into the molecular defects underlying the condition.

Received June 18, 2003. Accepted in final form December 4, 2003.

Additional material related to this article can be found on the Neurology Web site. Go to www.neurology.org and scroll down to the Table of Contents for the May 11 issue to find the link for this article.

This article has been cited by other articles:

				D. Fischer and N. B. Romero Reply to: Myopathic (not neuropathic) electrophysiologic abnormalities in dynamin 2-related centronuclear myopathy Brain, February 1, 2007; 130(2): e64 - e64. [Full Text] [PDF]

				V. Tosch, H. M. Rohde, H. Tronchere, E. Zanoteli, N. Monroy, C. Kretz, N. Dondaine, B. Payrastre, J.-L. Mandel, and J. Laporte A novel PtdIns3P and PtdIns(3,5)P2 phosphatase with an inactivating variant in centronuclear myopathy Hum. Mol. Genet., November 1, 2006; 15(21): 3098 - 3106. [Abstract] [Full Text] [PDF]

				D. Fischer, M. Herasse, M. Bitoun, H. M. Barragan-Campos, J. Chiras, P. Laforet, M. Fardeau, B. Eymard, P. Guicheney, and N. B. Romero Characterization of the muscle involvement in dynamin 2-related centronuclear myopathy Brain, June 1, 2006; 129(6): 1463 - 1469. [Abstract] [Full Text] [PDF]

				O. Nakagawa, M. Arnold, M. Nakagawa, H. Hamada, J. M. Shelton, H. Kusano, T. M. Harris, G. Childs, K. P. Campbell, J. A. Richardson, et al. Centronuclear myopathy in mice lacking a novel muscle-specific protein kinase transcriptionally regulated by MEF2 Genes & Dev., September 1, 2005; 19(17): 2066 - 2077. [Abstract] [Full Text] [PDF]

				M. Pele, L. Tiret, J.-L. Kessler, S. Blot, and J.-J. Panthier SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dog Hum. Mol. Genet., July 1, 2005; 14(13): 1905 - 1906. [Full Text] [PDF]

				M. Pele, L. Tiret, J.-L. Kessler, S. Blot, and J.-J. Panthier SINE exonic insertion in the PTPLA gene leads to multiple splicing defects and segregates with the autosomal recessive centronuclear myopathy in dogs Hum. Mol. Genet., June 1, 2005; 14(11): 1417 - 1427. [Abstract] [Full Text] [PDF]

				H. H. Goebel Congenital Myopathies in the New Millennium J Child Neurol, February 1, 2005; 20(2): 94 - 101. [Abstract] [PDF]